Close Menu

NEW YORK (GenomeWeb) – MDxHealth announced today that it has signed a distribution agreement with IPS Genomix for its SelectMDx for Prostate Cancer test in the Middle East.

IPS Genomix will distribute the test in Lebanon, Egypt, the United Arab Emirates, Saudi Arabia, Oman, Bahrain, Qatar, and Jordan. The company will also handle reimbursement for SelectMDx within the Middle East. MDxHealth, meanwhile, will perform the SelectMDx testing service in its ISO-certified clinical diagnostic laboratory in Nijmegen, the Netherlands.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.